HighPoint Advisor »

Revance Therapeutics shares owned by HighPoint Advisor

Quarter-by-quarter ownership of Revance Therapeutics (RVNC) shares owned by HighPoint Advisor from 13F filings

Historical chart of HighPoint Advisor investment in Revance Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Revance Therapeutics held by HighPoint Advisor consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Revance Therapeutics by HighPoint Advisor

Quarter filed Position value Share count Share price at filing
2023-12-31 $52k 11k 4.66

More positions owned by HighPoint Advisor

Apple Common Stock (AAPL)
Microsoft Corp Common Stock (MSFT)
Nvidia Corp Common Stock (NVDA)
Amazon.com Common Stock (AMZN)
Jpmorgan Chase & Co Common Stock (JPM)
Abbvie Common Stock (ABBV)
Meta Platforms Inc Cl A Common Stock (META)
Alphabet Inc Cl A Common Stock (GOOGL)
Exxon Mobil Corp Common Stock (XOM)
Berkshire Hathaway Inc Cl B Common Stock (BRK.B)
Alphabet Inc Cl C Common Stock (GOOG)
Procter & Gamble Common Stock (PG)
Coca-cola Consolidated Common Stock (COKE)
Cme Group Inc Cl A Common Stock (CME)
Tesla Common Stock (TSLA)

View all positions for HighPoint Advisor

Top funds holding Revance Therapeutics

Palo Alto Investors
Vanguard Group
Franklin Resources
Jpmorgan Chase & Co
Bamco
Walleye Trading Advisors
Goldman Sachs Group
Rice Hall James & Associates
Charles Schwab Investment Management
Citadel Advisors
Wellington Management Company
D. E. Shaw & Co
HighTower Advisors
Balyasny Asset Management
Barclays

View all funds holding Revance Therapeutics